Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name LINC00152
   Synonyms CYTOR, C2orf59, LINC00152, NCRNA00152, MGC4677
   Region GRCh38_2:87454781-87636740    Sequence
   Ensembl ENSG00000222041
   RefSeq NR_024204
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name glioma
   ICD-0-3  M9380/3
   Methods qPCR, Luciferase reporter assay, in vitro knockdown
   Sample glioma tissues, cell lines (U87, LN229, U251, and T98G, NHAs)
   Expression Pattern up-regulated
   Function Description

LINC00152 was found to be significantly upregulated in human glioma cell lines and clinical samples.Knockdown of LINC00152 suppressed glioma cell proliferation, migration, and invasion in vitro.LINC00152 knockdown inhibits tumor growth.LINC00152 binds to miR-16 in a sequence-specific manner and suppresses its expression. miR-16 inhibition strongly attenuated LINC00152 knockdown-mediated suppressive effects on proliferation, migration, and invasion.LINC00152 induced BMI1 expression by sponging miR-16,this effect further promoted glioma cell proliferation and invasion.LINC00152 as an oncogenic lncRNA promoting glioma cell proliferation and invasion and as a potential target for human glioma treatment.

   Pubmed ID 29669323
   Year 2018
   Title Long Intergenic Noncoding RNA 00152 Promotes Glioma Cell Proliferation and Invasion by Interacting with MiR-16.
   External Links
   Links for  LINC00152 GenBank       HGNC       lncrnadb       Noncode
   Links for  glioma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.